Associate Professor Naomi Allen
BSc, MSc, DPhil
Associate Professor in Epidemiology
- Clinical Trial Service Unit
Naomi Allen is an Associate Professor in Epidemiology, based in the Clinical Trial Service Unit and Epidemiological Studies Unit. She has worked predominantly on large-scale prospective studies such as EPIC and the Million Women Study and has a keen research interest in the role of diet, hormones and circulating biomarkers in cancer development. She is co-Principal Investigator of the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group, which aims to conduct individual pooled analyses of the relationship between circulating biomarkers and prostate cancer risk from cohort studies from around the world. In 2011, she became Senior Epidemiologist for UK Biobank and helps co-ordinate record linkage of routine health-related datasets into the study.
Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study.
Perez-Cornago A. et al, (2017), British Journal of Cancer, 117, 1562 - 1571
Anti-Mullerian hormone and endometrial cancer: a multi-cohort study.
Fortner RT. et al, (2017), British Journal of Cancer
Comparison of sociodemographic and health-related characteristics of UK Biobank participants with the general population
Fry A. et al, (2017), American Journal of Epidemiology
UK Biobank: Opportunities for cardiovascular research
Littlejohns TJ. et al, (2017), European Heart Journal
Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women.
Jung S. et al, (2017), Fertil Steril, 107, 1012 - 1022.e2